Rowatinex, 30 capsules, Rowa Wagner

Prophylaxis and treatment of urinary lithiasis.

Adjuvant in the treatment of mild-moderate urinary tract infections and nephropathies.

Pharmacotherapeutic group: other urological products, urinary antispasmodics.

Composition:

One gastro-resistant soft capsule contains alpha-pinene 24.8 mg, beta-pinene 6.2 mg, camphene 15 mg, cineole 3 mg, fenchone 4 mg, borneol 10 mg, anethole 4 mg and excipients: capsule contents - olive oil, capsule - gelatin, glycerol 85%, sodium ethyl hydroxybenzoate, sodium propyl hydroxybenzoate, (E217), Sunset yellow FCF (E110), quinoline yellow (E104).

How to use:

• Adults: the usual dose is one Rowatinex capsule 3-4 times a day, 30 minutes before meals or as recommended by the doctor.
• Children aged 6 to 14 years: the usual dose is one Rowatinex capsule 1-2 times a day, 30 minutes before meals or as recommended by the doctor.
• On the recommendation of the doctor, during very painful periods, especially if colic pain occurs, a dose of 20-30 oral drops of Rowatinex solution is administered, which can be repeated after 15-20 minutes if necessary, or up to 40 oral drops of Rowatinex solution are administered in a single dose.
• Children aged 6 to 14 years. The usual dose is 1-2 oral drops of Rowatinex solution 3-4 times a day, 30 minutes before meals or as recommended by the doctor.

Adverse reactions:

• Occasionally, mild and transient gastric disturbances have been reported.
• Rarely, vomiting has been reported.
• Two mild cases of drug intolerance have been reported.
• Allergic reactions, even delayed, may occur (see Precautions).

Overdose:

• In case of overdose, gastric irritation with nausea, vomiting and diarrhea may occur.
• If the drug was swallowed recently, gastric lavage should be performed.
• The patient should be closely monitored and, if necessary, symptomatic treatment should be instituted. Cardiac, respiratory, renal and hepatic function should be monitored.
• Toxicological studies in animals have shown that high doses of essential oils can cause central nervous system depression with stupor and respiratory failure or central nervous system stimulation to the point of excitation and convulsions.

Contraindications:

Severe renal colic, anuria, serious urinary tract infections, urinary stones requiring surgical treatment.

Precautions:

• Because the capsules contain Sunset yellow FCF (E110), allergic reactions may occur.
• Due to the p-hydroxybenzoate ester content of the capsule, Rowatinex capsules may cause allergic reactions (even delayed).

Interactions:

Caution should be exercised in patients treated with anticoagulants or other drugs metabolized by the liver that have a narrow therapeutic index.

Warnings:

• In patients with renal colic, medical supervision of treatment is recommended.
• Pregnancy and lactation: Although no teratogenic effects have been reported, Rowatinex should not be administered during the first trimester of pregnancy. As insufficient information is available, Rowatinex should not be administered to breast-feeding women.
• Ability to drive or use machines: Rowatinex does not affect the ability to drive or use machines.
• Do not use after the expiry date stated on the packaging.
• Store below 25°C, in the original packaging.
• Keep out of reach of children.

Presentation: 30 capsules